Distinguished in Gliosarcoma

Dr. Jaishri Blakeley

Neurology

Johns Hopkins Medicine

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 5, Floor 5,

Baltimore, MD

Offers Telehealth

Distinguished in Gliosarcoma

Johns Hopkins Medicine

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 5, Floor 5,

Baltimore, MD

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care.

Dr. Blakeley is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

Her clinical research consists of co-authoring 187 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency

Johns Hopkins University School of Medicine, Neurology, 2005

Specialties

Neurology

Licenses

Psychiatry & Neurology in MD

Board Certifications

American Board Of Psychiatry And Neurology

Fellowships

Johns Hopkins University School of Medicine, 2007

Hospital Affiliations

The Johns Hopkins Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem

Capital Blue Cross

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
OTHER MEDICARE PART D
PPO

CareFirst

Cigna

First Health

INSURANCE PLAN
MEDICARE PDP
PPO

Geisinger

Highmark

Humana

HMO
INDEMNITY
POS
PPO

Johns Hopkins Healthcare

HMO
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE-MEDICAID PLAN

Managed Medicaid

OTHER MANAGED MEDICAID

Medicaid

OTHER MEDICAID
STATE MEDICAID

Medicare

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE PART D

UnitedHealthcare

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 10 Less Insurance Carriers -

Locations

Johns Hopkins Outpatient Center
601 North Caroline Street, Floor 5, Floor 5, Baltimore, MD 21287

Call: 410-955-9441

Other Locations

Skip Viragh Outpatient Cancer Center
201 North Broadway Street, Viragh BLDG 5th FL, Baltimore, MD 21287

Call: 410-955-8964

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
10753 Falls Road, Pavilion II STE 115, Lutherville, MD 21093

Call: 410-955-9441

Additional Areas of Focus

Dr. Blakeley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Enrollment Status: Active_not_recruiting

Publish Date: October 02, 2025

Intervention Type: Drug

Study Drug: Brigatinib

Study Phase: Phase 2

A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas